Lilly cancels trials for experimental MS drug-WEB ONLY
Eli Lilly and Co. watched $97 million and a whole lot of hope wash down the drain yesterday. The Indianapolis-based drugmaker and a development partner canceled clinical trials on an experimental drug to treat multiple sclerosis when the drug failed to delay progression of the disease in clinical trial patients. Lilly had partnered with the […]